GAL1R blocked the proliferation of tumor cells through the activation of ERK1/2 and cyclin-dependent kinase inhibitors, leading to cell-cycle arrest (regulating cell cycle control proteins such as cyclin D1, p57, p27) [123,196,198,200]. Here, GALR1 is linked to neoplasm.